leukemia

leukemia

Tags - leukemia
TEHRAN, September 15 -Lumoxiti injection has been approved to treat certain instances of relapsed or refractory "hairy cell" leukemia, or HCL, the U.S. Food and Drug Administration said Thursday.
News ID: 28853   Publish Date : 2018/09/15